Glioma Clinical Trials
Glioma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for glioma. Corterve aggregates actively recruiting Glioma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Glioma studies
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.NCT05355701PHASE1PfizerFayetteville, Arkansas
- Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid TumorsNCT07628634EARLY_PHASE1University of California, IrvineOrange, California
- Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade GliomasNCT07110246PHASE2University of California, San FranciscoBirmingham, Alabama
- A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade GliomaNCT04166409PHASE3National Cancer Institute (NCI)Birmingham, Alabama
- Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care RadiationNCT07076498PHASE1M.D. Anderson Cancer CenterHouston, Texas
- PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN AmplificationsNCT06161519PHASE1, PHASE2National Cancer Institute (NCI)Bethesda, Maryland
- A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsNCT05538130PHASE1PfizerBirmingham, Alabama
- A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade GliomaNCT07464925PHASE1Tetragon Biosciences LtdTampa, Florida
- A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)NCT05099003PHASE1, PHASE2National Cancer Institute (NCI)Birmingham, Alabama
- Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaNCT06860594PHASE1National Cancer Institute (NCI)Duarte, California
- Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent GlioblastomaNCT07416188PHASE1, PHASE2National Institute of Neurological Disorders and Stroke (NINDS)Bethesda, Maryland
- Imaging of Solid Tumors Using 18F-TRXNCT06942104PHASE1Rahul AggarwalSan Francisco, California
Glioma trials by state
Glioma trials by metro
Frequently asked questions
- How do I find recruiting Glioma clinical trials?
- Corterve aggregates actively recruiting Glioma studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Glioma clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Glioma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.